Logo image of 33L.DE

LULULEMON ATHLETICA INC (33L.DE) Stock Fundamental Analysis

Europe - FRA:33L - US5500211090 - Common Stock

141.44 EUR
+0.66 (+0.47%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to 33L. 33L was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. 33L gets an excellent profitability rating and is at the same time showing great financial health properties. 33L has a correct valuation and a medium growth rate. These ratings would make 33L suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

33L had positive earnings in the past year.
33L had a positive operating cash flow in the past year.
In the past 5 years 33L has always been profitable.
33L had a positive operating cash flow in each of the past 5 years.
33L.DE Yearly Net Income VS EBIT VS OCF VS FCF33L.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

33L has a better Return On Assets (23.74%) than 100.00% of its industry peers.
33L has a better Return On Equity (40.70%) than 95.83% of its industry peers.
The Return On Invested Capital of 33L (29.67%) is better than 97.92% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 33L is significantly above the industry average of 11.21%.
Industry RankSector Rank
ROA 23.74%
ROE 40.7%
ROIC 29.67%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
33L.DE Yearly ROA, ROE, ROIC33L.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

Looking at the Profit Margin, with a value of 16.38%, 33L belongs to the top of the industry, outperforming 89.58% of the companies in the same industry.
33L's Profit Margin has been stable in the last couple of years.
33L has a Operating Margin of 22.92%. This is amongst the best in the industry. 33L outperforms 89.58% of its industry peers.
In the last couple of years the Operating Margin of 33L has remained more or less at the same level.
33L has a Gross Margin of 59.10%. This is comparable to the rest of the industry: 33L outperforms 45.83% of its industry peers.
In the last couple of years the Gross Margin of 33L has remained more or less at the same level.
Industry RankSector Rank
OM 22.92%
PM (TTM) 16.38%
GM 59.1%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
33L.DE Yearly Profit, Operating, Gross Margins33L.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 33L is creating value.
33L has less shares outstanding than it did 1 year ago.
33L has less shares outstanding than it did 5 years ago.
There is no outstanding debt for 33L. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
33L.DE Yearly Shares Outstanding33L.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
33L.DE Yearly Total Debt VS Total Assets33L.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

An Altman-Z score of 7.37 indicates that 33L is not in any danger for bankruptcy at the moment.
33L has a Altman-Z score of 7.37. This is amongst the best in the industry. 33L outperforms 89.58% of its industry peers.
33L has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.37
ROIC/WACC3.01
WACC9.86%
33L.DE Yearly LT Debt VS Equity VS FCF33L.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

33L has a Current Ratio of 2.27. This indicates that 33L is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of 33L (2.27) is better than 85.42% of its industry peers.
A Quick Ratio of 1.16 indicates that 33L should not have too much problems paying its short term obligations.
The Quick ratio of 33L (1.16) is better than 77.08% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.16
33L.DE Yearly Current Assets VS Current Liabilites33L.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.88% over the past year.
Measured over the past years, 33L shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.37% on average per year.
The Revenue has grown by 9.16% in the past year. This is quite good.
33L shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.62% yearly.
EPS 1Y (TTM)8.88%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%-1.59%
Revenue 1Y (TTM)9.16%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%6.5%

3.2 Future

33L is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.74% yearly.
The Revenue is expected to grow by 5.77% on average over the next years.
EPS Next Y-9.34%
EPS Next 2Y-4.86%
EPS Next 3Y-0.82%
EPS Next 5Y6.74%
Revenue Next Year3.87%
Revenue Next 2Y4.2%
Revenue Next 3Y4.97%
Revenue Next 5Y5.77%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
33L.DE Yearly Revenue VS Estimates33L.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
33L.DE Yearly EPS VS Estimates33L.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.23, the valuation of 33L can be described as reasonable.
Based on the Price/Earnings ratio, 33L is valued cheaply inside the industry as 93.75% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.42. 33L is valued rather cheaply when compared to this.
33L is valuated correctly with a Price/Forward Earnings ratio of 12.42.
83.33% of the companies in the same industry are more expensive than 33L, based on the Price/Forward Earnings ratio.
33L is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.23
Fwd PE 12.42
33L.DE Price Earnings VS Forward Price Earnings33L.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 33L is valued a bit cheaper than 77.08% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 33L is valued a bit cheaper than the industry average as 68.75% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.77
EV/EBITDA 6.19
33L.DE Per share data33L.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

33L has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.46
EPS Next 2Y-4.86%
EPS Next 3Y-0.82%

0

5. Dividend

5.1 Amount

No dividends for 33L!.
Industry RankSector Rank
Dividend Yield N/A

LULULEMON ATHLETICA INC

FRA:33L (10/17/2025, 7:00:00 PM)

141.44

+0.66 (+0.47%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)09-04 2025-09-04/amc
Earnings (Next)12-03 2025-12-03/amc
Inst Owners88.49%
Inst Owner ChangeN/A
Ins Owners0.32%
Ins Owner ChangeN/A
Market Cap16.77B
Analysts65.64
Price Target180.36 (27.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.13%
Min EPS beat(2)-1.37%
Max EPS beat(2)5.62%
EPS beat(4)3
Avg EPS beat(4)2.97%
Min EPS beat(4)-1.37%
Max EPS beat(4)5.62%
EPS beat(8)7
Avg EPS beat(8)4.26%
EPS beat(12)10
Avg EPS beat(12)4.28%
EPS beat(16)14
Avg EPS beat(16)5.09%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-2.5%
Max Revenue beat(2)-1.43%
Revenue beat(4)0
Avg Revenue beat(4)-1.28%
Min Revenue beat(4)-2.5%
Max Revenue beat(4)-0.26%
Revenue beat(8)0
Avg Revenue beat(8)-1.59%
Revenue beat(12)3
Avg Revenue beat(12)-0.84%
Revenue beat(16)5
Avg Revenue beat(16)-0.43%
PT rev (1m)0.8%
PT rev (3m)-35.15%
EPS NQ rev (1m)-6.14%
EPS NQ rev (3m)-26.25%
EPS NY rev (1m)-9.83%
EPS NY rev (3m)-10.45%
Revenue NQ rev (1m)-0.67%
Revenue NQ rev (3m)-3.76%
Revenue NY rev (1m)-0.48%
Revenue NY rev (3m)-2.46%
Valuation
Industry RankSector Rank
PE 11.23
Fwd PE 12.42
P/S 1.8
P/FCF 16.77
P/OCF 10.25
P/B 4.47
P/tB 4.66
EV/EBITDA 6.19
EPS(TTM)12.59
EY8.9%
EPS(NY)11.39
Fwd EY8.05%
FCF(TTM)8.43
FCFY5.96%
OCF(TTM)13.8
OCFY9.76%
SpS78.72
BVpS31.67
TBVpS30.36
PEG (NY)N/A
PEG (5Y)0.46
Profitability
Industry RankSector Rank
ROA 23.74%
ROE 40.7%
ROCE 41.88%
ROIC 29.67%
ROICexc 36.8%
ROICexgc 38.25%
OM 22.92%
PM (TTM) 16.38%
GM 59.1%
FCFM 10.71%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
ROICexc(3y)45.65%
ROICexc(5y)41.54%
ROICexgc(3y)46.74%
ROICexgc(5y)45.9%
ROCE(3y)41.97%
ROCE(5y)38.1%
ROICexcg growth 3Y-2.73%
ROICexcg growth 5Y3.8%
ROICexc growth 3Y3.22%
ROICexc growth 5Y3.16%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
F-Score6
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 154.46%
Cap/Sales 6.82%
Interest Coverage 250
Cash Conversion 64.15%
Profit Quality 65.41%
Current Ratio 2.27
Quick Ratio 1.16
Altman-Z 7.37
F-Score6
WACC9.86%
ROIC/WACC3.01
Cap/Depr(3y)181.68%
Cap/Depr(5y)168.92%
Cap/Sales(3y)7.05%
Cap/Sales(5y)6.53%
Profit Quality(3y)77.23%
Profit Quality(5y)86.23%
High Growth Momentum
Growth
EPS 1Y (TTM)8.88%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%-1.59%
EPS Next Y-9.34%
EPS Next 2Y-4.86%
EPS Next 3Y-0.82%
EPS Next 5Y6.74%
Revenue 1Y (TTM)9.16%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%6.5%
Revenue Next Year3.87%
Revenue Next 2Y4.2%
Revenue Next 3Y4.97%
Revenue Next 5Y5.77%
EBIT growth 1Y8.67%
EBIT growth 3Y22.21%
EBIT growth 5Y23.02%
EBIT Next Year9.59%
EBIT Next 3Y5.94%
EBIT Next 5Y6.88%
FCF growth 1Y20.52%
FCF growth 3Y16.77%
FCF growth 5Y32.6%
OCF growth 1Y16.98%
OCF growth 3Y17.83%
OCF growth 5Y27.7%